| Breaking in and busting out: Cell-penetrating peptides and the endosomal escape problem JC LeCher, SJ Nowak, JL McMurry Biomolecular concepts 8 (3-4), 131-141, 2017 | 118 | 2017 |
| Genistein has antiviral activity against herpes B virus and acts synergistically with antiviral treatments to reduce effective dose JC LeCher, N Diep, PW Krug, JK Hilliard Viruses 11 (6), 499, 2019 | 55 | 2019 |
| Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside S Tao, K Zandi, L Bassit, YT Ong, K Verma, P Liu, JA Downs-Bowen, ... Current research in pharmacology and drug discovery 2, 100045, 2021 | 33 | 2021 |
| Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes B Dobosh, K Zandi, DM Giraldo, SL Goh, K Musall, M Aldeco, J LeCher, ... Cell Reports 39 (11), 2022 | 13 | 2022 |
| B virus (Macacine Herpesvirus 1) divergence: variations in glycoprotein D from clinical and laboratory isolates diversify virus entry strategies I Patrusheva, L Perelygina, I Torshin, J LeCher, J Hilliard Journal of Virology 90 (20), 9420-9432, 2016 | 13 | 2016 |
| Synthesis of Novel N4-Hydrocytidine Analogs as Potential Anti-SARS-CoV-2 Agents F Amblard, JC LeCher, R De, SL Goh, C Li, M Kasthuri, N Biteau, L Zhou, ... Pharmaceuticals 15 (9), 1144, 2022 | 5 | 2022 |
| Utilization of a cell‐penetrating peptide‐adaptor for delivery of human papillomavirus protein E2 into cervical cancer cells to arrest cell growth and promote cell death JC LeCher, HL Didier, RL Dickson, LR Slaughter, JC Bejarano, S Ho, ... Cancer Reports 6 (5), e1810, 2023 | 4 | 2023 |
| Synthesis of 4′-Substituted Carbocyclic Uracil Derivatives and Their Monophosphate Prodrugs as Potential Antiviral Agents NG Biteau, SA Amichai, N Azadi, R De, J Downs-Bowen, JC Lecher, ... Viruses 15 (2), 544, 2023 | 4 | 2023 |
| Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections SJ Hurwitz, R De, JC LeCher, JA Downs-Bowen, SL Goh, K Zandi, ... Viruses 16 (4), 651, 2024 | 2 | 2024 |
| Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease F Amblard, JC LeCher, R De, S Zhou, P Liu, SL Goh, S Tao, D Patel, ... European Journal of Medicinal Chemistry 268, 116263, 2024 | 2 | 2024 |
| Discovery of a 2′-Fluoro, 2′-bromouridine phosphoramidate prodrug exhibiting anti-yellow fever virus activity in culture and in mice JC LeCher, K Zandi, VV Costa, F Amblard, S Tao, D Patel, S Lee, ... Microorganisms 10 (11), 2098, 2022 | 2 | 2022 |
| Utilization of a cell-penetrating peptide-adaptor for delivery of HPV protein E2 into cervical cancer cells to arrest cell growth and promote cell death JC LeCher, HL Didier, RL Dickson, LR Slaughter, JC Bejarano, S Ho, ... biorxiv, 2020.01. 31.928358, 2020 | 1 | 2020 |
| Stably-Inverted Apical-Out Human Upper Airway Organoids for SARS-CoV-2 Infection and Therapeutic Testing JH Lee, JC LeCher, E Parigoris, N Shinagawa, J Sentosa, C Manfredi, ... bioRxiv, 2024 | | 2024 |
| Use of Cell Penetrating Peptides to Deliver Cargo in Protists MV Warner, Z Barnhill, JC LeCher, JL Cooper The FASEB Journal 33 (S1), 659.4-659.4, 2019 | | 2019 |
| Characterization of eNOS ser‐600 Phosphorylation: A Link to the Cell Cycle K Patel, J Lecher, C Chrestensen The FASEB Journal 33 (S1), 632.9-632.9, 2019 | | 2019 |
